A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome
- Status
- TERMINATED
- Phase
- PHASE1
Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Effect of BMS-986165 on the Blood Levels of Metformin
- Status
- COMPLETED
- Phase
- PHASE1
CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Drug Levels and Safety of Pegbelfermin in Healthy Overweight and Obese Chinese and Korean Participants
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2